Literature DB >> 34511192

Evolving Concepts Regarding Radiation Therapy for Pancreatic Cancer.

William A Hall1, Beth Erickson2, Christopher H Crane3.   

Abstract

In todays practice most institutions individualize the use of adjuvant, neoadjuvant, and definitive RT based on their interpretation of the available data. This review highlights novel concepts and approaches to the use of RT that should be considered by the surgical oncologist.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MR-guided RT for pancreatic cancer; MR-guided radiation therapy; Pancreatic radiation dose escalation

Mesh：

Year:  2021        PMID： 34511192      PMCID： PMC8462521          DOI： 10.1016/j.soc.2021.06.009

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN： 1055-3207            Impact factor:   2.402


  37 in total

1.  FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.

Authors:  Thierry Conroy; Pascal Hammel; Mohamed Hebbar; Meher Ben Abdelghani; Alice C Wei; Jean-Luc Raoul; Laurence Choné; Eric Francois; Pascal Artru; James J Biagi; Thierry Lecomte; Eric Assenat; Roger Faroux; Marc Ychou; Julien Volet; Alain Sauvanet; Gilles Breysacher; Frédéric Di Fiore; Christine Cripps; Petr Kavan; Patrick Texereau; Karine Bouhier-Leporrier; Faiza Khemissa-Akouz; Jean-Louis Legoux; Béata Juzyna; Sophie Gourgou; Christopher J O'Callaghan; Claire Jouffroy-Zeller; Patrick Rat; David Malka; Florence Castan; Jean-Baptiste Bachet
Journal:  N Engl J Med       Date:  2018-12-20       Impact factor: 91.245

Review 2.  The pancreas cancer microenvironment.

Authors:  Christine Feig; Aarthi Gopinathan; Albrecht Neesse; Derek S Chan; Natalie Cook; David A Tuveson
Journal:  Clin Cancer Res       Date:  2012-08-15       Impact factor: 12.531

Review 3.  Techniques of Vascular Resection and Reconstruction in Pancreatic Cancer.

Authors:  George Younan; Susan Tsai; Douglas B Evans; Kathleen K Christians
Journal:  Surg Clin North Am       Date:  2016-10-14       Impact factor: 2.741

4.  Percutaneous Irreversible Electroporation as First-line Treatment of Locally Advanced Pancreatic Cancer.

Authors:  Christopher Månsson; Richard Brahmstaedt; Peter Nygren; Anders Nilsson; Jozef Urdzik; Britt-Marie Karlson
Journal:  Anticancer Res       Date:  2019-05       Impact factor: 2.480

5.  DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer.

Authors:  Christine A Iacobuzio-Donahue; Baojin Fu; Shinichi Yachida; Mingde Luo; Hisashi Abe; Clark M Henderson; Felip Vilardell; Zheng Wang; Jesse W Keller; Priya Banerjee; Joseph M Herman; John L Cameron; Charles J Yeo; Marc K Halushka; James R Eshleman; Marian Raben; Alison P Klein; Ralph H Hruban; Manuel Hidalgo; Daniel Laheru
Journal:  J Clin Oncol       Date:  2009-03-09       Impact factor: 44.544

6.  Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01).

Authors:  Katsuhiko Uesaka; Narikazu Boku; Akira Fukutomi; Yukiyasu Okamura; Masaru Konishi; Ippei Matsumoto; Yuji Kaneoka; Yasuhiro Shimizu; Shoji Nakamori; Hirohiko Sakamoto; Soichiro Morinaga; Osamu Kainuma; Koji Imai; Naohiro Sata; Shoichi Hishinuma; Hitoshi Ojima; Ryuzo Yamaguchi; Satoshi Hirano; Takeshi Sudo; Yasuo Ohashi
Journal:  Lancet       Date:  2016-06-02       Impact factor: 79.321

7.  Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma.

Authors:  Joseph M Herman; Daniel T Chang; Karyn A Goodman; Avani S Dholakia; Siva P Raman; Amy Hacker-Prietz; Christine A Iacobuzio-Donahue; Mary E Griffith; Timothy M Pawlik; Jonathan S Pai; Eileen O'Reilly; George A Fisher; Aaron T Wild; Lauren M Rosati; Lei Zheng; Christopher L Wolfgang; Daniel A Laheru; Laurie A Columbo; Elizabeth A Sugar; Albert C Koong
Journal:  Cancer       Date:  2014-12-23       Impact factor: 6.860

Review 8.  EUS-guided radiofrequency ablation as an alternative to surgery for pancreatic neuroendocrine neoplasms: Who should we treat?

Authors:  Alberto Larghi; Gianenrico Rizzatti; Mihai Rimbaş; Stefano Francesco Crino; Antonio Gasbarrini; Guido Costamagna
Journal:  Endosc Ultrasound       Date:  2019 Jul-Aug       Impact factor: 5.628

Review 9.  Systematic Review of Irreversible Electroporation Role in Management of Locally Advanced Pancreatic Cancer.

Authors:  Stefano Lafranceschina; Oronzo Brunetti; Antonella Delvecchio; Maria Conticchio; Michele Ammendola; Giuseppe Currò; Tullio Piardi; Nicola de'Angelis; Nicola Silvestris; Riccardo Memeo
Journal:  Cancers (Basel)       Date:  2019-11-03       Impact factor: 6.639

10.  Ablative Five-Fraction Stereotactic Body Radiation Therapy for Inoperable Pancreatic Cancer Using Online MR-Guided Adaptation.

Authors:  Comron Hassanzadeh; Soumon Rudra; Ani Bommireddy; William G Hawkins; Andrea Wang-Gillam; Ryan C Fields; Bin Cai; Justin Park; Olga Green; Michael Roach; Lauren Henke; Hyun Kim
Journal:  Adv Radiat Oncol       Date:  2020-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.